Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Client Area Book a 7-day Readout
GliaPharm SA logo — Targeting Glial Cells and Brain Metabolism to Treat Neurolog...

GliaPharm SA

Targeting Glial Cells and Brain Metabolism to Treat Neurological Diseases

Founded 2016 Switzerland Geneva, Switzerland 11 employees Grant Total: $6.30M Biotechnology, Health Care

General Information

Company Name GliaPharm SA
Founded Year 2016
Location Switzerland Geneva, Switzerland
Employees 11
Industries Biotechnology, Health Care
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with GliaPharm SA. To contact GliaPharm SA, visit gliapharm.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does GliaPharm SA compare?

A PDF of GliaPharm SA and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting GliaPharm SA soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About GliaPharm SA

GliaPharm is a Swiss-based biotechnology company founded in 2016, specializing in the development of treatments for neurological and psychiatric disorders. The company's slogan "Targeting Glial Cells and Brain Metabolism to Treat Neurological Diseases" encapsulates its innovative approach.

GliaPharm focuses on targeting glial cells, which are the 'support cells' of neurons, to sustain and enhance brain metabolism in pathological conditions. With a vision to become a leading biotechnology company, it places emphasis on glia-mediated pathways as agents for neuroprotection and maintenance of cognitive functions.

The company's recent milestone includes securing $4.20M in grant investment on 15 December 2023, with the Alzheimer's Drug Discovery Foundation being the noteworthy investor. Operating within the biotechnology and health care industries, GliaPharm's headquarters are based in Switzerland.

Business keywords: neurological disorders, psychiatric disorders, glial cells, brain metabolism, neuroprotection, cognitive functions, Switzerland, therapeutic approach, biopharmaceuticals

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $4.20M 1
Alzheimer's Drug Discovery Foundation
15 Dec 2023
Debt Financing Fr.100.00K 1
FONGIT Innovation Fund
04 Jul 2022
Seed Round Fr.2.00M 1
Gliaven
26 May 2020
Non Equity Assistance Undisclosed 1
MassChallenge
MassChallenge
23 May 2017

GliaPharm SA Alternatives & Competitors

View All Alternatives
GliaPharm SA vs
GliaCure
GliaCure

Pioneering advancements in neurotherapies by harnessing the power of glial cells.

Venture round
Biotechnology, Health Care
GliaPharm SA vs
Lys Therapeutics
Lys Therapeutics France

First-in-class biotherapies against neurological diseases. Targeting neuroinflammation to tackle n...

Non Equity Assistance
13 employees
Biotechnology, Health Care
GliaPharm SA vs
Cavion
Cavion

Empowering therapies for cancer and neurologic diseases through pioneering ion channel inhibition

Series A
Biotechnology, Health Care
View all alternatives

FAQ About GliaPharm SA

Targeting Glial Cells and Brain Metabolism to Treat Neurological Diseases
GliaPharm SA was founded in 2016.
GliaPharm SA is headquartered in Geneva, Switzerland.
GliaPharm SA operates in Biotechnology and Health Care. Its work centres on neurological disorders, psychiatric disorders, glial cells and brain metabolism.
GliaPharm SA has approximately 11 employees.
GliaPharm SA has completed 4 funding rounds, raising a total of $6.30M. The latest funding stage is Grant.
Top alternatives and competitors to GliaPharm SA include GliaCure, Lys Therapeutics, Cavion, Cadent Therapeutics, Rubedo Life Sciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
GliaPharm SA and GliaCure are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for GliaPharm SA, https://bouncewatch.com/company/gliapharm, updated 29 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout